About Lucid Scientific
Lucid Scientific is a Healthcare company based in Atlanta (United States) founded in 2012 by Walker Inman. Real-time cell analyzers are developed for oxygen consumption monitoring. Lucid Scientific has raised $12.73 million across 2 funding rounds from investors including IAG Capital Partners, GRA Venture Fund and Dynamk Capital. Lucid Scientific offers products and services including Resipher and 96-Well Plate Integration. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Cell Based Assays. Its legal entity is Lucid Scientific, Inc. Its competitors include Kiyatec, CytoTronics and Indigo Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
Lucid Scientific was founded in 2012 in Atlanta, United States, within the biotechnology sector. Real-time cell analyzers, such as the RESIPHER system, are produced to monitor non-invasive oxygen consumption rates in 96-well incubator plates. Continuous data recording is enabled through on-plate monitors integrated with plastic lids. Hand-held monitors for cell cultures are also provided, supporting analytical operations in research environments.
- Headquarters Atlanta, United States
- Founders Walker Inman
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website lucidsci.com
- Social LinkedIn X Instagram
- Legal Name Lucid Scientific, Inc.
- Total Equity Funding$12.73M (USD)
in 2 rounds
- Latest Funding Round$9.16M (USD), Series A
Sep 2023
- InvestorsIAG Capital Partners
& 2 more
Products & Services of Lucid Scientific
Lucid Scientific offers a comprehensive portfolio of products and services, including Resipher and 96-Well Plate Integration.
Non-invasive system for measuring oxygen consumption in cell cultures.
Enables precise dynamic oxygen monitoring for research applications.
Funding Insights of Lucid Scientific
Lucid Scientific has successfully raised a total of $12.73M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $9.16 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $12.73M
- Total Rounds 2
- Last Round Series A — $9.16M
- First Round $3.57M
(Sep 2020)
- Investors Count 3
All 2 funding rounds of Lucid Scientific with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2023 | $9.16M | Series A | – | IAG Capital Partners | |
| Sep 2020 | $3.57M | Seed | – | Dynamk Capital |
3 investors in total: 3 institutional.
Investors in Lucid Scientific
Lucid Scientific has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include IAG Capital Partners, GRA Venture Fund and Dynamk Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are provided by IAG Capital Partners. | iagcapitalpartners.com | Charleston, USA | ||
Seed & early stage sector-agnostic venture capital firm funding companies in the US | graventurefund.org | Atlanta, United States | ||
Investment in life sciences innovation is facilitated by Dynamk Capital. | dynamk.vc | New York, United States |
Investor details for Lucid Scientific
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lucid Scientific
1 people are tracked at Lucid Scientific (1 in leadership).
| Name | Role | Group |
|---|---|---|
Walker Inman | Founder | Leadership |
Complete people profiles for Lucid Scientific
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Lucid Scientific
3 dated milestones of Lucid Scientific across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Lucid Scientific is founded.
- Funding First funding round of $3.6M.
- Funding Latest funding round, Series A, of $9.2M.
Competitors of Lucid Scientific
Lucid Scientific has 3 listed competitors in our database, 3 of them funded. They include Kiyatec, CytoTronics and Indigo Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kiyatec.com | 2005 | Pendleton, United States | $29.49M | Kiyatec is focused on revolutionizing cancer care through predictive platforms. | ||
| cytotronics.com | 2015 | Boston, United States | $22.75M | 22 | Cell-based assays for drug discovery are developed via CMOS platform. | |
| indigobiosciences.com | 2005 | State College, United States | $1.28M | 17 | Nuclear receptor and in vitro toxicology solutions are provided. |
Detailed competitors of Lucid Scientific
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Lucid Scientific
The website of Lucid Scientific (lucidsci.com) receives about 9.1K visits a month.
- Monthly visits9.1K
▲ 88.5% vs previous month
Websites whose visitors overlap most with Lucid Scientific. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Lucid Scientific (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lucid Scientific
Complete news archive for Lucid Scientific
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lucid Scientific
Lucid Scientific was founded in 2012 and raised its 1st funding round 8 years after it was founded.
Lucid Scientific is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Lucid Scientific is a funded company, having raised a total of $12.73M across 2 funding rounds to date. The company's 1st funding round was a Seed of $3.57M, raised on Sep 2020.
Lucid Scientific was founded in 2012 in Atlanta, United States, within the biotechnology sector. Real-time cell analyzers, such as the RESIPHER system, are produced to monitor non-invasive oxygen consumption rates in 96-well incubator plates. Continuous data recording is enabled through on-plate monitors integrated with plastic lids. Hand-held monitors for cell cultures are also provided, supporting analytical operations in research environments.
Lucid Scientific's top competitors include CytoTronics, Kiyatec and Indigo Biosciences.
Lucid Scientific offers Resipher and 96-Well Plate Integration.
Lucid Scientific has 3 investors. Key investors include IAG Capital Partners, GRA Venture Fund, and Dynamk Capital.
Lucid Scientific operates through Lucid Scientific, Inc..